Trade Mark Journal No.2026/020 15 May 2026

UK00004378245 24 April 2026 (5)

RESTORE

International priority date claimed: 16 January 2026 (United States of America) (99599102)

Class 5: Medicated and pharmaceutical preparations for use in the treatment of menstrual migraine; Prescription medicines for the treatment of menstrual migraine.

Axsome Therapeutics, Inc.

Representative: Keltie LLP